Excited to share my dissertation work, out today in @NatureComms! Big question being asked: in developing targeted degraders for tuberculosis infection, how do we find suitable targets for this novel antibiotic modality?
๐:https://t.co/WN1B2QFg5C
A reminder of what cancer research & effective translation to the clinic can enable for a subtype of acute leukemia that was mostly lethal in our lifetimes. The figure is marked up with pertinent years courtesy of
@DrSamuelBHume from this original review:
https://t.co/hLKOvLVK0e
First pole, first hat-trick, first Grand Slam, 7 wins, 16 podiums, 410 points, & lead the Championship for more than half the season ๐
So much to be proud of... and he inspired the Nation in the process! ๐ฆ๐บ
Keep your head up, Oscar. Weโll see you back home in Melbourne very soon ๐ซถ
Excited to share my dissertation work, out today in @NatureComms! Big question being asked: in developing targeted degraders for tuberculosis infection, how do we find suitable targets for this novel antibiotic modality?
๐:https://t.co/WN1B2QFg5C
It is great to see the President recognize academic medical innovation, and the eventual impact on patients. Left out one BIG thing: Without massive private venture capital and other private funding based on strong patents, both these drugs would not exist. At all. Zero. None.
Scientific dishonesty is tricky to untangle, but ultimately the responsibility lies with management, especially CEO & CSO. Culture emanates from the top down and pressure to produce results creates conflicting incentives.
Sprint at the killer experiments, don't avoid them
"It was an immense privilege to be immersed in the world-class scientific investigation occurring within IID, but the best part was the incredible sense of community felt among the people doing the research," says Harry Won (@harimwon), 2023 #IIDgraduate.